Texas
A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
A first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return.
UCLA researchers found that boosting p53 protein with navtemadlin helped T cells fight melanoma cancer cells longer, but dosing challenges remain.
Discussion (0)
No comments yet. Start the conversation!